Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-01-01 @ 8:10 AM
Study NCT ID:
NCT05203458
Status:
COMPLETED
Last Update Posted:
2024-05-16
First Post:
2021-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-20
First Submit QC Date:
None
Study First Post Date:
2022-01-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-15
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL